NCT02514694View on ClinicalTrials.gov

LEO 32731 - A Phase I Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Psoriasis Vulgaris

Interventions

DRUG

LEO32731

OTHER

Placebo

Trial Locations (1)

LS2 9LH

Covance CRU, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY